1
|
Goodman SM, Mehta BY, Kahlenberg CA, Krell EC, Nguyen J, Finik J, Figgie MP, Parks ML, Padgett DE, Antao VC, Yates AJ, Springer BD, Lyman SL, Singh JA. Response to Letter to the Editor on "Assessment of a Satisfaction Measure for Use After Primary Total Joint Arthroplasty". J Arthroplasty 2020; 35:3418-3419. [PMID: 32712120 DOI: 10.1016/j.arth.2020.07.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Accepted: 07/01/2020] [Indexed: 02/02/2023] Open
Affiliation(s)
- Susan M Goodman
- Department of Rheumatology, Hospital for Special Surgery, New York, NY
| | - Bella Y Mehta
- Department of Rheumatology, Hospital for Special Surgery, New York, NY
| | | | - Ethan C Krell
- Department of Orthopedics, Hospital for Special Surgery, New York, NY
| | - Joseph Nguyen
- Department of Biostatistics, Hospital for Special Surgery, New York, NY
| | - Jackie Finik
- Department of Rheumatology, Hospital for Special Surgery, New York, NY; Memorial Sloan Kettering Cancer Center, New York, NY
| | - Mark P Figgie
- Department of Orthopedics, Hospital for Special Surgery, New York, NY
| | - Michael L Parks
- Department of Orthopedics, Hospital for Special Surgery, New York, NY
| | - Douglas E Padgett
- Department of Orthopedics, Hospital for Special Surgery, New York, NY
| | - Vinicius C Antao
- Department of Value Management, Hospital for Special Surgery, New York, NY
| | - Adolph J Yates
- Department of Orthopedics, University of Pittsburgh, Pittsburgh, PA
| | | | - Steven L Lyman
- Department of Biostatistics, Hospital for Special Surgery, New York, NY
| | - Jasvinder A Singh
- The University of Alabama at Birmingham Medical Center, Birmingham, AL
| |
Collapse
|
2
|
Goodman SM, Mehta BY, Kahlenberg CA, Krell EC, Nguyen J, Finik J, Figgie MP, Parks ML, Padgett DE, Antao VC, Yates AJ, Springer BD, Lyman SL, Singh JA. Assessment of a Satisfaction Measure for Use After Primary Total Joint Arthroplasty. J Arthroplasty 2020; 35:1792-1799.e4. [PMID: 32173615 DOI: 10.1016/j.arth.2020.02.039] [Citation(s) in RCA: 37] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/14/2020] [Revised: 02/10/2020] [Accepted: 02/18/2020] [Indexed: 02/01/2023] Open
Abstract
BACKGROUND Patient satisfaction after total hip (THA) and total knee arthroplasty (TKA) is a core outcome selected by the Outcomes Measurement in Rheumatology. Up to 20% of THA/TKA patients are dissatisfied. Improving patient satisfaction is hindered by the lack of a validated measurement tool that can accurately measure change. METHODS The psychometric properties of a proposed satisfaction instrument, consisting of 4 questions rated on a Likert scale, scored 1-100, were tested for validity, reliability, and sensitivity to change using data collected between 2007 and 2011 in an arthroplasty registry. RESULTS We demonstrated construct validity by confirming our hypothesis; satisfaction correlated with similar constructs. Satisfaction correlated moderately with pain relief (TKA ρ = 0.61, THA ρ = 0.47) and function (TKA ρ = 0.65, THA ρ = 0.51) at 2 years; there was no correlation with baseline/preoperative pain/function values, as expected. Overall Cronbach's alpha >0.88 confirmed internal consistency. Test-retest reliability with weighted kappa ranged 0.60-0.75 for TKA and 0.36-0.56 for THA. Hip disability and Osteoarthritis Outcome Score/Knee injury and Osteoarthritis Outcome Scores quality of life improvement (>30 points) corresponds to a mean satisfaction score of 93.2 (standard deviation, 11.5) after THA and 90.4 (standard deviation, 13.8) after TKA, and increasing relief of pain and functional improvement increased the strength of their association with satisfaction. The satisfaction measure has no copyright and is available free of cost and represents minimal responder burden. CONCLUSION Patient satisfaction with THA/TKA can be measured with a validated 4-item questionnaire. This satisfaction measure can be included in a total joint arthroplasty core measurement set for total joint arthroplasty trials.
Collapse
Affiliation(s)
- Susan M Goodman
- Hospital for Special Surgery, Department of Rheumatology, New York, NY
| | - Bella Y Mehta
- Hospital for Special Surgery, Department of Rheumatology, New York, NY
| | | | - Ethan C Krell
- Hospital for Special Surgery, Department of Orthopedics, New York, NY
| | - Joseph Nguyen
- Hospital for Special Surgery, Department of Biostatistics, New York, NY
| | - Jackie Finik
- Hospital for Special Surgery, Department of Rheumatology, New York, NY; Memorial Sloan Kettering Cancer Center, New York, NY
| | - Mark P Figgie
- Hospital for Special Surgery, Department of Orthopedics, New York, NY
| | - Michael L Parks
- Hospital for Special Surgery, Department of Orthopedics, New York, NY
| | - Douglas E Padgett
- Hospital for Special Surgery, Department of Orthopedics, New York, NY
| | - Vinicius C Antao
- Hospital for Special Surgery, Department of Value Management, New York, NY
| | - Adolph J Yates
- Department of Orthopedics, University of Pittsburgh, Pittsburgh, PA
| | | | - Steven L Lyman
- Hospital for Special Surgery, Department of Biostatistics, New York, NY
| | - Jasvinder A Singh
- The University of Alabama at Birmingham Medical Center, Birmingham, AL
| |
Collapse
|
3
|
Prill R, Singh JA, Seeber GH, Nielsen SM, Goodman S, Michel S, Kopkow C, Schulz R, Choong P, Hommel H. Patient, physiotherapist and surgeon endorsement of the core domain set for total hip and total knee replacement in Germany: a study protocol for an OMERACT initiative. BMJ Open 2020; 10:e035207. [PMID: 32595152 PMCID: PMC7322286 DOI: 10.1136/bmjopen-2019-035207] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
INTRODUCTION There is a lack of harmonising measures for clinical trials on total joint replacement (TJR) that would allow for results from TJR studies to be compared or pooled. The Outcome Measures in Rheumatology (OMERACT) TJR core domain set is already endorsed among patients and physicians in the USA and Australia. Physiotherapists use different types of measurements compared to orthopaedic surgeons while both make substantial contributions to research in the field of TJR. To achieve consensus on core measurements sets, patients, physiotherapists and orthopaedic surgeons need to achieve consensus on the core domains for TJR trials. METHODS AND ANALYSIS For this multistage study, first, the OMERACT TJR core domain set survey will be translated to German and validated according to WHO guidelines. Next, the TJR core domain set will be considered for endorsement in different German stakeholder groups including patients, physiotherapists and orthopaedic surgeons. ETHICS AND DISSEMINATION Ethical approval for this protocol was given by the ethics committee of the Brandenburg University of Technology Cottbus-Senftenberg (BTU-CS, EK 2019-2). This article is based on the protocol version 2.5 from 6 May 2020. Anonymous data will be presented only. We will publish the results in peer-reviewed publications and at international conferences. TRIAL REGISTRATION NUMBER German Clinical Trials Registry (DRKS00016015).
Collapse
Affiliation(s)
- Robert Prill
- Therapy Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany
| | - Jasvinder A Singh
- Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA
- Medicine Service, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA
| | - Gesine H Seeber
- University Hospital of Orthopedics and Trauma Surgery Pius-Hospital, Medical Campus University Oldenburg, Oldenburg, Germany
| | - Sabrina Mai Nielsen
- Musculoskeletal Statistics Unit, The Parker Institute, Frederiksberg, Denmark
| | - Susan Goodman
- Integrative Rheumatology and Orthopedics Center of Excellence, Weill Cornell Medicine, Hospital for Special Surgery, New York, New York, USA
| | - Sven Michel
- Therapy Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany
| | - Christian Kopkow
- Therapy Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany
| | - Robert Schulz
- Therapy Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany
| | - Peter Choong
- Department of Surgery, St. Vincent's Hospital Melbourne, The University of Melbourne, Melbourne, Victoria, Australia
| | - Hagen Hommel
- Klinik für Orthopädie, Sportmedizin und Rehabilitation, Krankenhaus Markisch-Oderland GmbH, Wriezen, Germany
| |
Collapse
|
4
|
Song Y, Zhong X, Gao P, Zhou C, Shi J, Wu Z, Guo Z, Wang Z. Aspirin and Its Potential Preventive Role in Cancer: An Umbrella Review. Front Endocrinol (Lausanne) 2020; 11:3. [PMID: 32038497 PMCID: PMC6989406 DOI: 10.3389/fendo.2020.00003] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/09/2019] [Accepted: 01/06/2020] [Indexed: 12/22/2022] Open
Abstract
Background: Aspirin is one of the most commonly prescribed drugs worldwide and has been reported to possess anti-cancer properties in addition to antipyretic and analgesic effects. This umbrella review summarizes systematic reviews and meta-analyses that investigate the association between aspirin and cancer risk, aiming to help clinical and public health decision-makers interpret the results of these studies when re-positioning aspirin. Methods: An umbrella review of systematic reviews and meta-analyses. Results: The associations that reached statistical significance (17 in total) indicated potential preventive effects of aspirin on certain cancers or precancerous lesions. We found that no association was supported by strong evidence. Only one association (aspirin and overall cancer risk) was supported by highly suggestive evidence. The evidence supporting the association between aspirin and the risk of breast cancer, non-cardia gastric cancer, or prostate cancer was considered to be highly suggestive. The remaining 23 associations were supported by weak (13) or not suggestive evidence (10). Conclusions: The association between aspirin and a reduced risk of esophageal squamous cell carcinoma is supported by strong evidence, researchers and policy makers should pay more attention to the potential merit of repositioning aspirin to prevent esophageal squamous cell carcinoma.
Collapse
|
5
|
Hoang A, Goodman SM, Navarro-Millán IY, Mandl LA, Figgie MP, Bostrom MP, Padgett DE, Sculco PK, McLawhorn AS, Singh JA. Patients and surgeons provide endorsement of core domains for total joint replacement clinical trials. Arthritis Res Ther 2017; 19:267. [PMID: 29208013 PMCID: PMC5718077 DOI: 10.1186/s13075-017-1476-9] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2017] [Accepted: 11/16/2017] [Indexed: 01/06/2023] Open
Abstract
Background Our objective in this study was to examine whether stakeholders further endorse the core domain set proposed by the Outcome Measures in Rheumatology Trials (OMERACT) total joint replacement (TJR) working group. Methods We emailed a survey to 3810 hip/knee arthroplasty patients and 49 arthroplasty surgeons at a high-volume arthroplasty center to rate the importance of each core domain (i.e., pain, function, patient satisfaction, revision surgery, adverse events, and death) and two additional domains (i.e., cost and participation). Ratings were on a 1–9 scale, with 1–3 indicating limited or no importance for patients, 4–6 being important but not critical, and 7–9 being critical. We calculated median (IQR) values and compared ratings by sex, age, and participant type using the Wilcoxon rank-sum test. Results The questionnaire was completed by 1295 patients (34%) and 21 surgeons (43%). Patient nonresponders were similar to responders in age (≥55 years, 85.7% vs. 88.6%), sex (female, 57.5% vs. 57.3%), and joint procedure (total hip replacement, 56.9% vs. 63.2%). Overall, all core domains and one noncore domain (i.e., participation) were confirmed as “critical” by both stakeholder groups. Cost was rated as only “important” but not “critical” by surgeons. A completed consensus for all the core domains persisted even when we stratified by sex, age, arthritis type, and the affected joint (knee vs. hip). We received suggestions for additional critical domains from 217 patients and 5 surgeons, prompting the inclusion of 2 research agenda items. Conclusions Our study confirmed a consensus rating of the OMERACT TJR core domain set as critical for patients. This broad endorsement should encourage the identification of candidate outcome instruments to further develop a TJR core measurement set that can harmonize reporting in TJR clinical trials.
Collapse
Affiliation(s)
- Anh Hoang
- Division of Rheumatology, Hospital for Special Surgery, New York, NY, USA
| | - Susan M Goodman
- Division of Rheumatology, Hospital for Special Surgery, New York, NY, USA
| | | | - Lisa A Mandl
- Division of Rheumatology, Hospital for Special Surgery, New York, NY, USA
| | - Mark P Figgie
- Department of Orthopedic Surgery, Hospital for Special Surgery, New York, NY, USA
| | - Mathias P Bostrom
- Department of Orthopedic Surgery, Hospital for Special Surgery, New York, NY, USA
| | - Douglas E Padgett
- Department of Orthopedic Surgery, Hospital for Special Surgery, New York, NY, USA
| | - Peter K Sculco
- Department of Orthopedic Surgery, Hospital for Special Surgery, New York, NY, USA
| | | | - Jasvinder A Singh
- Medicine Service, VA Medical Center, 510 20th Street South, Faculty Office Tower 805B, Birmingham, AL, USA. .,Department of Medicine, School of Medicine, University of Alabama at Birmingham, 1720 Second Avenue South, Birmingham, AL, 35294-0022, USA. .,Division of Epidemiology, School of Public Health, University of Alabama at Birmingham, 1720 Second Avenue South, Birmingham, AL, 35294-0022, USA. .,University of Alabama at Birmingham, Faculty Office Tower 805B, 510 20th Street South, Birmingham, AL, 35294, USA.
| |
Collapse
|